Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 12.09 USD -3.59% Market Closed
Market Cap: 338.3m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+40%
Revenue
Forecast
+4%
Operating Income
Forecast
+25%
Net Income
Forecast
+19%

Wall Street
Price Targets

CLPT Price Targets Summary
Clearpoint Neuro Inc

Wall Street analysts forecast CLPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLPT is 28.22 USD with a low forecast of 25.25 USD and a high forecast of 31.5 USD.

CLPT Lowest Forecast
Wall Street Target
25.25 USD
109% Upside
CLPT Average Forecast
Wall Street Target
28.22 USD
133% Upside
CLPT Highest Forecast
Wall Street Target
31.5 USD
161% Upside
Lowest
Price Target
25.25 USD
109% Upside
Average
Price Target
28.22 USD
133% Upside
Highest
Price Target
31.5 USD
161% Upside
Clearpoint Neuro Inc Competitors:
Price Targets
IMR
Imricor Medical Systems Inc
40% Upside
4543
Terumo Corp
23% Upside
7575
Japan Lifeline Co Ltd
20% Upside
7779
Cyberdyne Inc
70% Upside
IMR
Imricor Medical Systems Inc
40% Upside
4543
Terumo Corp
23% Upside
7575
Japan Lifeline Co Ltd
20% Upside
7779
Cyberdyne Inc
70% Upside
EKF
EKF Diagnostics Holdings PLC
32% Upside
DCTH
Delcath Systems Inc
42% Upside

Revenue
Forecast

Revenue Estimate
Clearpoint Neuro Inc

For the last 8 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 24%. The projected CAGR for the next 3 years is 34%.

24%
Past Growth
34%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Clearpoint Neuro Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Clearpoint Neuro Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss
What are analyst estimates?

See Also

Summary
CLPT intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLPT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLPT stock valuation using valuation multiples.
Wall Street Estimates
CLPT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLPT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLPT's stock price target?
Price Target
28.22 USD

According to Wall Street analysts, the average 1-year price target for CLPT is 28.22 USD with a low forecast of 25.25 USD and a high forecast of 31.5 USD.

What is Clearpoint Neuro Inc's Revenue forecast?
Projected CAGR
34%

For the last 8 years the compound annual growth rate for Clearpoint Neuro Inc's revenue is 24%. The projected CAGR for the next 3 years is 34%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.